drugset / Trial / NCT05821712

A New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems

NCT05821712 ↗

Phase 3 Completed 80 enrolled Colgate Palmolive
RandomizedParallel-groupTriple-blindPrevention

Summary

This 6-month clinical study was designed to investigate clinical efficacy on plaque and gingivitis for the Meridol Base Mouthwash containing 0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride as compared to a Negative Control Mouthwash containing 0.057% sodium fluoride after 3 and 6 months of product use.

Timeline

Start
2021-03-08
Primary completion
2021-09-24
Completion
2021-09-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Meridol Base Mouthwash Unknown — —
Comparator Negative Control Mouthwash Unknown — —

Indications